F15063, a potential antipsychotic with dopamine D₂/D₃ antagonist, 5-HT_1A agonist and D₄ partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

By Assié Marie-Bernadette   Bardin Laurent   Auclair Agnès   Consul-Denjean Nathalie   Sautel François   Depoortère Ronan   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 4, 2007-06 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite

The dopamine D₁ receptor agonist and D₂ receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats

By Milivojevič Nataša   Krisch Igor   Sket Dušan   Živin Marko  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 6, 2004-06 ,pp. : 576-582

Springer Publishing Company

Access to resources Recommend Favorite

The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D₁ agonist and D₂ antagonist

By Natesan Sridhar   Reckless Greg   Barlow Karen   Odontiadis John   Nobrega José   Baker Glen   George Susan   Mamo David   Kapur Shitij  

Psychopharmacology, Vol. 199, Iss. 2, 2008-08 ,pp. : 275-289

Springer Publishing Company

Access to resources Recommend Favorite

Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor

By Wood M.D.   Boyfield I.   Nash D.J.   Jewitt F.R.   Avenell K.Y.   Riley G.J.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Synthesis and in vitro structure-activity relationship of 13-tert-butyl-ergoline derivatives as 5-HT 1A receptor ligands

By Mantegani S.   Brambilla E.   Caccia C.   Fornaretto M.   Mc Arthur R.   Varasi M.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 10, 1997-10 ,pp. : 795-804

Elsevier

Access to resources Recommend Favorite